You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

PRISMA-IPD: Invitation to participate in developing a reporting guideline

PRISMA-IPD: Developing a reporting guideline for systematic reviews of individual participant data

Invitation to participate

The PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement is in widespread use and has proved useful for researchers and publishers. However, PRISMA was not developed with individual participant data (IPD) analyses in mind, and some items do not fit with the IPD approach. As a first step in developing an extension to guidance, we are gathering opinion on which PRISMA items are directly applicable to IPD, which require modification or replacement and what additional items are required.

The survey is accessible at the link provided below.

The PRISMA-IPD Steering Committee: Lesley Stewart, NIHR Centre for Reviews and Dissemination, University of York; Mike Clarke, MRC Methodology Hub, Queens University; Richard Riley, Public Health, Epidemiology and Biostatistics, University of Birmingham; Maroeska Rovers, Radboud University Medical Center Nijmegen; Jayne Tierney, MRC Clinical Trials Unit, London. Co-convenors of the Cochrane Collaboration IPD Meta-analysis Methods Group.

Contributor's Information
Contributor's name: 
Gavin Stewart
Email address:
Updated on: January 28, 2013, 22:12